Polyphyllin I Orchestrates Autophagy to Reprogram the Tumour Immune Microenvironment and Abrogate Cisplatin Resistance in Non‐Small Cell Lung Cancer
Clinical and Experimental Pharmacology and Physiology · 2026-08 · 53 (8)
DOI: 10.1111/1440-1681.70149 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Pharmacology and Physiology, online erschienen am 13.08.2026. Verfasst von Zongxu Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Yunnan University of Chinese Medicine, Kunming, China. Hauptthemen laut MEDLINE: Autophagy, Tumor Microenvironment, Cisplatin, Drug Resistance, Neoplasm. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Foundation for Innovative Research Groups of the National Natural Science Foundation of China, Yunnan Applied Basic Research Program, Yunnan Provincial Science and Technology Department-Applied Basic Research Joint Special Funds of Chinese Medicine.
Abstract (Originalsprache)
Objective
This study aims to elucidate the molecular mechanisms by which Polyphyllin I (PPI), a potent steroidal saponin, attenuates non‐small cell lung cancer (NSCLC) progression via mechanistic reprogramming of an autophagy‐dependent immunogenic response.
Methods
Integrated in vitro (A549, H460) and in vivo (LLC xenograft) models were deployed to evaluate PPI's efficacy on autophagic flux and the tumour immune microenvironment. The regulatory role of autophagy in macrophage‐mediated antigen presentation was scrutinised via ATG3‐mediated genetic silencing or overexpression in tumour‐macrophage co‐culture systems. Concurrently, the capacity of PPI to sensitise NSCLC cells to cisplatin (DDP) and counteract chemoresistance was evaluated.
Results
PPI activated the AMPK/p53/mTOR signalling axis, robustly inducing core autophagic markers (LC3‐II and Beclin‐1) in a dose‐dependent manner. Mechanistically, PPI‐induced autophagic flux served as a prerequisite for antitumoural M1 macrophage polarisation, characterised by significant upregulation of iNOS and MHC‐II in co‐cultured THP‐1 cells. Genetic knockdown of ATG3 effectively abrogated these immunostimulatory profiles, whereas ATG3 overexpression potentiated PPI‐driven antigen presentation. Furthermore, PPI administration markedly delayed the onset of DDP resistance sustained by functional autophagic flux. In vivo, PPI significantly suppressed tumour burden, accompanied by enhanced CD8+ T‐cell infiltration and elevated cytotoxic effector levels (IFN‐γ and Granzyme B).
Conclusion
Our findings establish PPI as a dual autophagic‐immune modulator that re‐engineers the immunosuppressive microenvironment. By coupling intracellular autophagic stress with macrophage‐mediated antigen presentation, PPI reinstates antitumour immunity and abrogates chemoresistance, offering a compelling therapeutic framework for managing recalcitrant NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Yunnan University of Chinese Medicine, Kunming, China.
- Department of Urology, The 1st Affiliated Hospital of Kunming Medical University, Kunming, China.
- The First Clinical Medical College, Yunnan University of Chinese Medicine, Kunming, China.
- Yunnan Key Laboratory of Southern Medicinal Utilization, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
Förderung
- Foundation for Innovative Research Groups of the National Natural Science Foundation of China
- Yunnan Applied Basic Research Program
- Yunnan Provincial Science and Technology Department-Applied Basic Research Joint Special Funds of Chinese Medicine
Zitieren
APA
Liu, Z., Li, Y., Li, S., Wang, Z., Zhao, H., Ke, K., Wan, C., & Shi, X. (2026). Polyphyllin I Orchestrates Autophagy to Reprogram the Tumour Immune Microenvironment and Abrogate Cisplatin Resistance in Non‐Small Cell Lung Cancer. Clinical and Experimental Pharmacology and Physiology, 53(8). https://doi.org/10.1111/1440-1681.70149
Vancouver
Liu Z, Li Y, Li S, Wang Z, Zhao H, Ke K, et al. Polyphyllin I Orchestrates Autophagy to Reprogram the Tumour Immune Microenvironment and Abrogate Cisplatin Resistance in Non‐Small Cell Lung Cancer. Clinical and Experimental Pharmacology and Physiology. 2026;53(8). doi:10.1111/1440-1681.70149
BibTeX
@article{Liu2026,
author = {Liu, Zongxu and Li, Yanping and Li, Shumin and Wang, Zhen and Zhao, Huilan and Ke, Kunbin and Wan, Chunping and Shi, Xinan},
title = {Polyphyllin I Orchestrates Autophagy to Reprogram the Tumour Immune Microenvironment and Abrogate Cisplatin Resistance in Non‐Small Cell Lung Cancer},
journal = {Clinical and Experimental Pharmacology and Physiology},
year = {2026},
volume = {53},
number = {8},
doi = {10.1111/1440-1681.70149}
}
EUVIMED